Chitosan and Its Derivatives in Clinical Use and Applications

Biodegradable Polymers in Clinical Use and Clinical Development

Volumn , Issue , 2011, Pages 111-135

  Subramanian, Anuradha ^a   Vasanthan, Kirthanashri Srinivasan ^a   Krishnan, Uma Maheswari ^a   Sethuraman, Swaminathan ^a  

^a SASTRA UNIVERSITY   (India)

Author keywords

Biodegradable polymers of natural origin chitosan, and its derivatives in applications; Chemical modifications to chitosan new biological activities, improving mechanical properties; Chitosan, for biomedical applications absorption, enhancing mucoadhesive and controlled release properties

Indexed keywords

EID: 84886578476     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118015810.ch4     Document Type: Chapter

References (103)

1. Hejazi, R. and M. Amiji. Chitosan-based gastrointestinal delivery systems.J. Control. Release 2003;89:151-165.
2. Wang, X.H., D.P. Li, W.J. Wang, Q.L. Feng, F.Z. Cui, Y.X. Xu, X.H. Song, and M. Werf. Cross linked collagen/chitosan matrix for articial livers. Biomaterials 2003;24:3213-3220.
3. Trapani, A., J. Sitterberg, U. Bakowsky, and T. Kissel. The potential of glycol chitosan nanoparticals as carrier for low water soluble drugs. Int.J. Pharm. 2009;375:97-106.
4. Wilson, B., M. Samanta, K. Santhi, K.P. Sampath Kumar, M. Ramasamy, and B. Suresh. Chitosan nanoparticles as a new delivery system for anti-Alzheimer drug tacrine. Nanomed. Nanotech. Biol. Med. 2010;6:144-152.
5. Senel, S. and S.J. Mc Clure. Potential applications of chitosan in veterinary medicine. Adv. Drug Deliv. Rev. 2004;56:1467-1480.
6. Germershaus, O., S. Mao, J. Sitterberg, U. Bakowsky, and T. Kissel. Gene delivery using chitosan, trimethyl chitosan or polyethylenglycol-graft-trimethyl chitosan block copolymers: Establishment of structure-activity relationships in vitro.J. Control. Release 2008;125:145-154.
7. Zhong, Z., X. Ji, R. Xing, S. Liu, Z. Guo, X. Chen, and P. Li. The preparation and antioxidant activity of the sulphanilamide derivatives of chitosan and chitosan sulfates. Bioorg. Med. Chem. 2007;15:3775-3782.
8. Rekha, M.R. and C.P. Sharma. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.J. Control. Release 2009;135:144-151.
9. Kotze, A.F., M.M. Thanou, H.L. Leuben, B.G. de Boer, V.J. Coos, and H.E. Junginger. Effect of the degree of quaternization of N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells. Eur.J. Pharm. Bio. Pharm. 1999;47:269-274.
10. Germershaus, O., S. Mao, J. Sitterberg, U. Bakowsky, and T. Kissel. Gene delivery using chitosan, trimethyl chitosan or polyethyleneglycol-graft-trimethyl chitosan block copolymers: Establishment of structure-activity relationships in vitro.J. Control. Release 2008;125:145-154.
11. Mphahlele, R. Drug release properties of cross linked N-carboxymethylated chitosan wafers. Mini dissertation. Tshwane University of Technology, South Africa, 2005.
12. Nunthanid, J., P. Sriamornsak, S. Limmatvapirat, S. Puttipipatkhachorn, L.Y. Lim, and E. Khor. Characterization of chitosan acetate as a binder for sustained release tablets.J. Control. Release 2004;99:15-26.
13. Chen, F., G. Luo, W. Yang, and Y. Wang. Preparation and adsorption ability of polysulfone microcapsules containing modified chitosan gels. Tsinghua Sci. Tech. 2005;10:535-541.
14. Chae, C.Y., S. Sohee, L. Minhyung, J.M. Kyeong, and N.J. Woon. Deoxycholic acid conjugated chitosan oligosaccharide nanoparticles for efficient gene carrier.J. Control. Release 2005;109:330-344.
15. Gao, Y., Z. Zhang, L. Chen, W. Gu, and Y. Li. Chitosan N betainates/DNA selfassembly nanoparticles for gene delivery: In vitro uptake and transfection efficiency. Int.J. Pharm. 2009;71:156-162.
16. Kafedjiiski, K., A.H. Krauland, M.H. Hoffer, and A. Bernkop-Schnurch. Synthesis and in vitro evaluation of a novel thiolated chitosan. Biomaterials 2005;26:819-826.
17. Kogana, G., Y.A. Skorik, I. Zitnanova, L. Krizkova, Z. Durackova, C.A. R. Gomes, Y.G. Yatluk, and J. Krajcovic. Antioxidant and antimutagenic activity of N-(2-carboxyethyl) chitosan. Toxicol. Appl. Pharm. 2004;201:303-310.
18. Baldrick, P. The safety of chitosan as a pharmaceutical excipient. Reg. Toxicol. Pharm. 2009, to appear.
19. Chatelet, C., O. Damour, and A. Domard. Influence of the degree of acetylation on some biological properties of chitosan films. Biomaterials 2001;22:261-268.
20. Dodane, V. and V.D. Vilivalam. Pharmaceutical applications of chitosan. PSTT 1998;1:246-253.
21. Mi,F.L., Y.B. Wu, and S.S. Shyu. Control ofwound infections using a bilayer chitosan wound dressing with sustainable antibiotic delivery. Biomed. Mater. Res. 2002;59:438.
22. Illum, L., I.J. Gill, M. Hinchcliffe, A.N. Fisher, and S.S. Davis. Chitosan as a novel nasal delivery system for vaccines. Adv. Drug Deliv. Rev. 2001;51:81-96.
23. Madihally, S.V. and H.W. T. Matthew. Porous chitosan scaffolds for tissue engineering. Biomaterials 1999;20:1133-1142.
24. Sinha, V.R., A.K. Singla, S. Wadhawan, S. Kaushik, R. Kumria, K. Bansal, and S. Dhawan. Chitosan microspheres as a potential carrier for drugs. Int.J. Pharm. 2004;247:1-33.
25. Je, J.Y., Y.S. Cho, and S.K. Kim. Cytotoxic activities of water-soluble chitosan derivatives with different degree of deacetylation. Bioorg. Med. Chem. Lett. 2006;16:2122-2126.
26. Gupta, K.C. and M.N. V. Ravi Kumar. Drug release behaviour of beads and micro granules of chitosan. Biomaterials 2000;21:1115-1119.
27. Chae, S.Y., M.K. Jang, and J.W. Nah. Influence of molecular weight on oral absorption of water soluble chitosans.J. Control. Release 2005;102:383-394.
28. Van Der Lubben, I.M., V.J. Coos, G. Borchard, and H.E. Junginger. Chitosan and its derivatives in mucosal drug and vaccine delivery. Eur.J. Pharm. Sci. 2001;14:201-207.
29. Nishimura, Y., H.S. Kim, N. Ikota, H. Arima, H.S. Bom, Y.H. Kim, Y. Watanabe, M. Yukawa, and T. Ozawa. Radioprotective effect of chitosan in sub-lethally X-ray irradiated mice.J. Radiat. Res. 2003;44:53-58.
30. Lee, K.Y., M. Shibutani, H. Takagi, T. Arimura, S. Takigami, C. Uneyama, N. Kato, and M. Hirose. Subchronic toxicity study of dietary N-acetylglucosamine in F344 rats. Food Chem. Toxicol. 2004;42(4):687-695.
31. Onishi, H. and Y. Machida. Biodegradation and distribution of water-soluble chitosan in mice. Biomaterials 1999;20:175-182.
32. Minami, S., M. Ohoka, Y. Okamoto, K. Miyatake, A. Matsuhashi, Y. Shigemasa, and Y. Fukumoto. Chitosan-inducing hemorrhagic pneumonia in dogs. Carbohydr. Polym. 1996;29:241-246.
33. Kean, T. and M. Thanou. Biodegradation, biodistribution and toxicity of chitosan. Adv. Drug Deliv. Rev. 2010;62:3-11.
34. Park, J.H., G. Saravanakumar, K. Kim, and I.C. Kwon. Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv. Drug Deliv. Rev. 2010;62:28-41.
35. Sun, Y. and A.J. Wan. Preparation of nanoparticles composed of chitosan and its derivatives as delivery systems for macromolecules.J. Appl. Polym. Sci. 2007;105:552-561.
36. Kim, E.M., H.J. Jeong, I.K. Park, C.S. Cho, C.G. Kim, and H.S. Bom. Hepatocyte-targeted nuclear imaging using 99mTc-galactosylated chitosan: Conjugation, targeting, and biodistribution.J. Nucl. Med. 2005;46:141-145.
37. Park, J.S., T.S. Han, K.Y. Lee, S.S. Han, J.J. Hwang, D.M. Moon, S.Y. Kim, and Y.N. Cho. N-acetyl histidine-conjugated glycol chitosan self-assembled nanoparticles forintracytoplasmic delivery of drugs: Endocytosis, exocytosis and drug release.J. Control. Release 2006;115:37-45.
38. Zhang, J., C.G. Xi, Y.Y. Li, and C.S. Liu. Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin. Nanomed. Nanotech. Biol. Med. 2007;3:258-265.
39. Lee, K.Y., J.H. Kim, I.C. Kwon, and S.Y. Jeong. Self aggregates of deoxycholic acid modiefied chitosan as a novel carrier of adriamycin. Colloid Polym. Sci. 2000;278:1216-1219.
40. Liu, C.G., K.G. H. Desai, X.G. Chen, and H.J. Park. Linolenic acid-modified chitosan for formation of self assembled nanoparticles.J. Agric. Food Chem. 2005;53:437-441.
41. Chen, X.G., C.M. Lee, and H.J. Park. O/W emulsification for the self aggregation and nanoparticle formation of linoleic acid modiefied chitosan in aqueous system.J. Agric. Food Chem. 2003;51:3135-3139.
42. Subramanian, A., U.M. Krishnan, and S. Sethuraman. Development of biomaterial scaffold for nerve tissue engineering: Biomaterial mediated neural regeneration.J. Biomed. Sci. 2009;16:108.
43. Amidi, M., E. Mastrobattista, W. Jiskoot, and W.E. Hennink. Chitosan-based delivery systems for protein therapeutics and antigens. Adv. Drug Deliv. Rev. 2010;62:59-82.
44. Urrusuno, F.R., P. Calvo, R.C. Lopez, J.L. Jato, and M.J. Lonso. Enhancement of nasal absorption of insulin using chitosan nanoparticles. Pharm. Res. 1999;16:1576-1581.
45. Kotze, A.F., M.M. Thanou, H.L. Lueben, A.G. De Boer, J.C. Verhoef, and H.E. Junginger. Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: In vitro evaluation in intestinal epithelial cells (Caco-2).J. Pharm. Sci. 1999;88,253-257.
46. Thanou,M., J.C. Verhoef, and H.E. Junginger. Oral drug absorption enhancement by chitosan and its derivatives. Adv. Drug Deliv. Rev. 2001;56:117-126.
47. Thanou, M.M., A.F. Kotze, T. Scharringhausen, H.T. Lueben, A.G. De Boer, J.C. Verhoef, and H.E. Junginger. Effect of degree of quaternization of N-trimethyl chitosan chloride for enhanced transport of hydrophilic compounds across intestinal Caco-2 cell monolayers.J. Control. Release 2000;64:15-25.
48. Sadeghi, A.M., F.A. Dorkoosh, M.R. Avadi, M. Weinhold, A. Bayat, F. Delie, R. Gurny, B. Larijani, M.R. Tehrani, and H.E. Junginger. Permeation enhancer effect of chitosan and chitosan derivatives: Comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells. Eur.J. Pharm. Biopharm. 2008;70:270-278.
49. Thanou, M.M., B.I. Florea, M.W. E. Langemeyer, J.C. Verhoef, and H.E. Junginger. N-trimethylated chitosan chloride (TMC) improves the intestinal permeation of the peptide drug buserelin in vitro (Caco-2 cell) and in vivo rats models. Pharm. Res. 2000;17:27-31.
50. Thanou, M., M.T. Nihot, M. Jansen, J.C. Verhoef, and H.E. Junginger. Mono-Ncarboxymethyl chitosan (MCC), a polyampholytic chitosan derivative, enhances the intestinal absorption of low molecular weight heparin across intestinal epithelia in vitro and in vivo.J. Pharm. Sci. 2001;90,38-46.
51. Schipper, N.G. M., S. Olsson, J.A. Hoogstraate, A.G. De Boer, K.M. Varum, and P. Artursson. Chitosans as absorption enhancers for poorly absorbable drugs.
52. Mechanism of absorption enhancement. Pharm. Res. 1997;14:923-929.
53. Kotze, A.F., H.L. Luessen, B.J. De Leeuw, A.G. de Boer, J.C. Verhoef, and H.E. Junginger. N-Trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: in vitro evaluation in intestinal epithelial cells(CaCo-2). pharm. Rev. 1997;14:1197-1202.
54. Kast, C.E., W. Frick, U. Losert, and A.B. Schnuürch. Chitosan-thioglycolic acid conjugate: A new scaffold material for tissue engineering. Int.J. Pharm. 2003;256:183-189.
55. Jeong, B., Y.K. Choi, Y.H. Bae, G. Zentner, and S.W. Kim. New biodegradable polymers for injectable drug delivery systems.J. Control. Release 1999;62:109-114.
56. Kast, C.E. and A.B. Schnürch. Thiolated polymers-thiomers: Development and in vitro evaluation of chitosan-thioglycolic acid conjugates. Biomaterials 2001;22:2345-2352.
57. Kast, C.E., W. Frick, U. Losert, and A.B. Schnürch. Chitosan-thioglycolic acid conjugate: A new scaffold material for tissue engineering. Int.J. Pharm. 2003;256:183-189.
58. Chang, S.J., C.C. Niu, C.F. Huang, and S.M. Kuo. Evaluation of chitosan-g-PEG copolymer for cell anti-adhesion application.J. Med. Biol. Eng. 2007;27 (1):41-46.
59. Jian Du, E. and Y.L. Hsieh. PEGylation of chitosan for improved solubility and ber formation via electrospinning. Cellulose 2007;14:543-552.
60. Brown, C.D., L. Kreilgaard, M. Nakakura, N.C. Lelham, P. Wayne, R. Gombotz, and A.S. Hoffman. Release of PEGylated granulocyte-macrophage colonystimulating factor from chitosan/glycerol films.J. Control. Release 2001;72:35-46.
61. Romaskevic, T., S. Budriene, A. Liubertiene, I. Gerasimcik, A. Zubriene, and G. Dienys. Synthesis of chitosan-graf-poly(ethylene glycol) methyl ether methacrylate copolymer and its application for immobilization of maltogenase. CHEMIJA 2007;18:33-38.
62. Glerentes, P., L. Vachoud, J. Doury, and A. Domard. Study of a chitin-based gel as injectable material in periodontal surgery. Biomaterials 2002;23:1295-1302.
63. Schipper, N.G. M., K.M. Varum, and P. Artursson. Chitosans as absorption enhancers for poorly absorbable drugs. 1. Influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (Caco-2) cells. Pharm. Res. 1996;13:1686-1692.
64. Rekha, M.R. and C.P. Sharma. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.J. Control. Release 2009;135:144-151.
65. Janes, K.A., P. Calvo, and M.J. Alonso. Polysaccheride colloidal particles as delivery systems for macromolecules. Adv. Drug Deliv. Rev. 2001;47:83-97.
66. Agnihotri, S.A., N.N. Mallikarjuna, and T.M. Aminabhavi. Recent advances on chitosan-based micro-and nanoparticles in drug delivery.J. Control. Release 2004;100:5-28.
67. Lubben, V.L. M., J.C. Verhoef, G. Borchard G, and H.E. Junginger. Chitosan for mucosal vaccination Adv. Drug Deliv. Rev. 2001;52:139-144.
68. Lubben, V.L. M., F. Konings, G. Borchard, J.C. Verhoef, and H.E. Jungier. In vivo uptake of chitosan microparticles by murine Peyer's patches: Visualization studies using confocal laser scanning microscopy and immunohistochemistry.J. Drug Target. 2001;9:39-47.
69. Kato, Y., H. Onishi, and Y. Machida. N-succinyl-chitosan as a drug carrier: Water insoluble and water soluble conjugates. Biomaterials 2004;25:907-915.
70. Senel, S., M.J. Kremer, S. Kas, P.W. Wertz, A.A. Hincal, and C.A. Aquier. Enhancing effect of chitosan on peptide drug delivery across buccal mucosa. Biomaterials 2000;21:2067-2071.
71. Lueben, H.L., B.J. LeeuwDe, M.W. Langemeyer, A.G. Boer, J.C. Verhoef, and H.E. Junginger. Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo. Pharm. Res. 1996;13:1668-1672.
72. Keong, L.C. and A.S. Halim. In vitro models in biocompatibility assessment for biomedical-grade chitosan derivatives in wound management. Int.J. Mol. Sci. 2009;10,1300-1313.
73. Angela, M. Chitosan nanoparticles: A new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. Int.J. Pharm. 2001;224:159-168.
74. Felt, O., P. Furrer, J.M. Mayer, B. Plazonnet, P. Buri, and R. Gurny. Topical use of chitosan in ophthalmology: Tolerance assessment and evaluation of precorneal retention. Int.J. Pharm. 1999;180:185-193.
75. Genta, I., B. Conti, P. Perugini, F. Pavaneto, A. Spadaro, and G. Puglisi. Bioadhesive microspheres for ophthalmic administration of acyclovir.J. Pharm. Pharmcol. 1997;49:737-742.
76. Liu, W., S. Sun, Z. Cao, X. Zhang, K. Yao, W.W. Lu, and K.D. K. Luk. An investigation on the physiochemical properties of chitosan/DNA polyelectrolyte complexes. Biomaterials 2005;26:2705-2711.
77. Lavertu, M., S. Methot, N.T. Khanh, and M.D. Buschmann. High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of melocular weight and degree of deacetylation. Biomaterials 2006;27: 4815-4824.
78. Gao, Y., Z. Zhang, L. Cen, W. Gu, and Y. Li. Chitosan N-betainates/DNA selfassembly nanoparticles for gene delivery: In vitro uptake and transfection efficiency. Int.J. Pharm. 2009;371:156-162.
79. Thanou, M., B. I Florea, M. Geldof, H.E. Junginger, and G. Borchard. Quaternized chitosan oligomers as novel gene delivery vectors in epithelial cell lines. Biomaterials 2002;23:153-159.
80. Corrigan, D.O., A.M. Healy, and O.I. Corrigan. Preparation and release of salbutamol from chitosan and chitosan co-spray dried compacts and multiparticulates. Eur.J. Pharm. Biopharm. 2006;62:295-305.
81. Cremer, B.K. and J. Kreuter. Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for antiinflammatory drugs.J. Control. Release 1996;39:17-25.
82. Nascimento, A., M.C. Laranjeira, V.T. Favere, and A. Josue. Impregnation and release of aspirin from chitosan/poly(acrylic acid) graft copolymer microspheres.J. Microencapsul 2001;18:679-684.
83. Obara, K., M. Ishihaarab, Y. Ozekia, T. Ishizukaa, T. Hayashib, S. Nakamuraa, Y. Saitod, H. Yurad, T. Matsuib, H. Hattorib, B. Takaseb, M. Ishiharac, M. Kikuchib, and T. Maeharaa. Controlled release of paclitaxel from photocrosslinked chitosan hydrogels and its subsequent effect on subcutaneous tumor growth in mice.J. Control. Release 2005;110:79-89.
84. Shu, X.Z. and K.J. Zhu. The influence of multivalent phosphate structure on the properties of ionically cross linked chitosan films for controlled drug release. Eur.J. Pharm. Biopharm. 2002;54:235-243.
85. Boucarda, N., C. Viton, D. Agay, E. Mari, T. Roger, Y. Chancerelle, and A. Domard. The use of physical hydrogels of chitosan for skin regeneration following third-degree burns. Biomaterials 2007;28:3478-3488.
86. Kweon, D.K., S.B. Song, and Y.P. Park. Preparation of water-soluble chitosan/ heparin complex and its application as wound healing accelerator. Biomaterials 2003;24:1595-1601.
87. Li, Z., H.R. Ramay, K.D. Hauch, D. Xiao, and M. Zhang. Chitosan/alginate hybrid scaffolds for bone tissue engineering. Biomaterials 2005;26:3919-3928.
88. Jiang, T., I. Wafa, I. Fattah, and C.T. Laurencin. In vitro evaluation of chitosan/ poly (lactic acid-glycolic acid) sintered microsphere scaffolds for bone tissue engineering. Biomaterials 2006;27:4894-4903.
89. Jin, R., L.S. M. Teixeira, P.J. Dijkstra, M. Karperien, C.A. Blitterswijk, Z.Y. Zhong, and J. Feijen. Injectable chitosan-based hydrogels for cartilage tissue engineering. Biomaterials 2009;30:2544-2551.
90. Deng, C.M., L.Z. He, M. Zhao, D. Yang, and Y. Liu. Biological properties of the chitosan-gelatin sponge wound dressing. Carbohyd. Polym. 2007;69: 583-589.
91. Attila, C., C. Yasemin, B. Irpanli, E. Bilensoyb, K. Yorgancia, C. Sema, Z. Saribas, and V. Kaynaroglua. Antibacterial activity of triclosan chitosan coated graft on hernia graft infection model. Int.J. Pharm. 2009;381:214-219.
92. Mi, F.L., Y.B. Wu, and S.S. Shyu. Control of wound infections using a bilayer chitosan wound dressing with sustainable antibiotic delivery. Biomed. Mater. Res. 2002;59:438.
93. Shi, C., Y. Zhu, X. Ran, M. Wang, Y. Su, and T. Cheng. Therapeutic potential of chitosan and its derivatives in regenerative medicine.J. Surg. Res. 2006;133:185-192.
94. Ta, H.T., C.R. Dass, and D.E. Dunstan. Injectable chitosan hydrogels for localised cancer therapy.J. Control. Release 2008;126:205-216.
95. Ruel-Gariepy, E., M. Shive, A. Bichara, M. Berrada, D.L. Garrec, A. Chenite, and J.-C. Leroux. A thermosensitive chitosan-based hydrogel for the local delivery of paclitaxel. Eur.J. Pharm. Biopharm. 2004;57:53-63.
96. Chiou, S.H., W.T. Wu, Y.Y. Huang, and T.W. Chung. Effects of the characteristics of chitosan on controlling drug release of chitosan coated PLLA microspheres.J. Microencapsul. 2001;18:613-625.
97. Kaushik, A., P.R. Solanki, A. Ansari, G. Sumana, A.S. Bansi, and D. Malhotra. Iron oxide-chitosan nanobiocomposite for urea sensor. Sensors Actuators 2009;138:572-580.
98. Wang, S.F. and Y.M. Tan. Novel amperometric immunosensor based on Fe3O4 magnetic nanoparticles/chitosan composite lm for determination of ferritin. Anal. Bioanal. Chem. 2007;387:703-708.
99. Solanki, P.R., A. Kaushik, A.A. Anees, G. Sumana, and B.D. Malhotra Zinc oxide-chitosan nanobiocomposite for urea sensor, Appl. Phys. Lett. 2008;93:163903. [online journal].
100. Khan, R., A. Kaushik, P.R. Solanki, A.A. Ansari, M.K. Pandey, and B.D. Malhotra. Zinc oxide nanoparticles-chitosan composite film for cholesterol. Biosensor. Anal. Chim. Acta 2008;616:207-213.
101. Kaushik, A., R. Khan, P.R. Solanki, P. Pandey, J. Alam, S. Ahmad, and B.D. Malhotra. Iron oxide nanoparticles-chitosan composite based glucose biosensor. Biosens. Bioelectron. 2008;24:676-683.
102. Kaushik, A., P.R. Solanki, A.A. Ansari, S. Ahmad, and B.D. Malhotra. Chitosan-ironoxide nanobiocomposite based immunosensor for ochratoxin-A. Electrochem. Commun. 2008;10:1364-1368.
103. Miao, Y. and S.N. Tan. Amperometric hydrogen peroxide biosensor based on immobilization of peroxidase in chitosan matrix crosslinked with glutaraldehyde. Analyst 2000;125:1591-1594.